1Man AL, Prieto-Garcia ME, Nicoletti C, et al. Improving M cell mediated transport across mucosal barriels: Do certain bacteria hold the keys ? [J]. Immunology, 2004, 113(1) :15 -22.
2Ye X, Jerebtsova M, Ray PE. Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney [J]. Hum Gene Ther, 2000, 11 (4) : 621 - 627.
4Schmiedlin-Ren P, Kesisoglou F, Mapili JA, et al. Increased transduction of human intestinal epithelial cells by adenoviral vectors in inflammatory bowel disease [ J ]. Inflamm Bowel Dis, 2005, 11 (5) : 464 - 472.
5Nakahira M, Ahn HJ, Park WR, et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1 [ J]. J Immunol, 2002, 168(3) : 1146 -1153.
6Wirtz S, Becker C, Blumberg R, et al. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA [ J ]. J Immunol, 2002, 168(1) :411 -420.
7Lindsay JO, Ciesielski CJ, Scheinin T, at al. The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10 [J]. J Immunol, 2001, 166(12) : 7625 -7633.
8Barbara G, Xing Z, Hogaboam CM, et al. Interleukin 10 gene transfer prevents experimental colitis in rats [J]. Gut, 2000, 46(3) : 344 -349.
10Lindsay JO, Ciesielski CJ, Scheinin T, et al. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis [J]. Gut, 2003, 52 ( 3 ) : 363 - 369.